Clinical Validation Study of the Eximis CS (Contained Segmentation) System
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Scott Chudnoff, MD
Maimonides Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Advent Health, 410 Celebration Place
Celebration, Florida, United States
- Rosemark Womens Care Specialists
Idaho Falls, Idaho, United States
- Maimonides Medical Center
Brooklyn, New York, United States
- Oregon Health and Science University School of Medicine
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Sept 2024
- Primary completion
- 1 Sept 2025
- Completion
- 25 Oct 2025
- Last update posted
- 30 Oct 2025
- Registered enrollment
- 23
- Registry id
- NCT06572163
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.